Cancer Drug Trial

WIN News talks to Race Oncology
11 Apr
Apr , 11 , 2022 Daniel Tillett

Race Oncology CSO Dr Daniel Tillett talks to WIN Television News about Race Oncology’s research collaboration with the University of Wollongong.

LinkedIn

Related posts:

Race Initiates Strategic Zantrene Formulation Collaboration with the University of Wollongong Race appoints Professor Michael Kelso as Principal Scientist Race appoints Dr Daniel Tillett Chief Scientific Officer